#Africa

In theory, starting antiretrovirals quiets the immune system, leading more immune cells to become part of the inactive reservoir.

That is according to a meta-analysis including nearly 500 people.

Researchers gave the vaccine, previously studied in Thailand, to participants in South Africa.

A recent study allayed concerns that certain forms of birth control were associated with an increased risk of acquiring the virus.

Events are scheduled throughout September to raise awareness about hep B and HIV in these communities.

Listen up: This powerhouse from Cameroon offers everyone an intentional conversation about power, privilege and accountability.

It likely aided the human species’s expansion but was eventually outmatched by an evolving virus.

The ordained Baptist reverend talks about the intersections of religion, HIV/AIDS and the South.

A look at September issues from the POZ archives

Formerly at Oxfam, Winnie Byanyima is the executive director of UNAIDS. She says fighting the epidemic is “very personal.”

The PopART study is one of three that have recently reported findings of such programs in sub-Saharan Africa.

The vaccine in the APPROACH study, which led to the Imbokodo and forthcoming Mosaico trails, prompted a robust immune response.

Poised for regulatory approval, the monthly vaginal ring appeared to lower the risk of HIV by about 39% overall in a recent study.

The program was associated with an impressive rise in viral suppression rates.

Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.

In 2015, research led the World Health Organization to recommend treating HIV regardless of CD4 count.